Sharepoint Solutions
PRODUCTS
-
Our research is powered by MRN owned, regulatory-approved and validated eClinical software systems. Our technology can be used at-site and at-home enabling fully integrated data through any clinical trial.
-
When it comes to your fill-finish workflow, sterility and efficiency are key. Denest and renest with confidence! Our ready-to-use (RTU) denesting equipment is here to help you separate and reassemble your products with ease. Rest assured the Hull i-Dositecno Denesting Equipment is robust and efficient, so your sterile, clean, ready to fill (SCF) components are transported smoothly through your fill-finish workflow.
-
With all the environmental challenges facing us today, doing everything we can to conserve and preserve our water is imperative. As you know, tens of thousands of leaks go undetected, equating to a staggering 6 billion gallons of water loss daily in the United States. To help combat this water loss, we have developed a program that provides you with the tools and knowledge to help find those undetected leaks. Our program is Leak Detection Pilot Program, and we want to partner with you.
-
ACS ATOMUS® PF8 features an NSF/ANSI 61 certified and proprietary filtration solution for the water treatment industry specifically designed to remove PFAS forever chemicals from drinking water.
-
Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.
WHITE PAPERS AND CASE STUDIES
-
Optimizing AAV Purification for High Recovery
How can you improve purification methods for your AAVs and enhance the efficacy and safety of your gene therapy treatments?
-
Removing Translation Bottlenecks With AI
See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.
-
Impact Of Immunogenicity On Efficacy And Safety Of Biosimilars
The presence of ADAs can affect the effectiveness and safety of biologic drugs. Read why regulatory agencies emphasize the need for extensive immunogenicity evaluation in biosimilar development.
-
The Impact Of Artificial Intelligence On CQV
AI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
Authentic Engagement: Reaching Underserved Lupus Patients
By partnering with the ICLF, see how we were able to gain access to and build trust with influential community leaders and advocates within the African American communities located near study sites.
-
Streamline Recruitment With Confidence
Transform your clinical trial recruitment with a service that delivers faster, more cost-effective enrollment, particularly for hard-to-reach populations.
-
Metropolitan Sewer District Of Greater Cincinnati
The Lower Mill Creek Partial Remedy (LMCPR) in Hamilton County, Ohio, is a large, complex effort to remove about 1.78 billion gallons of combined sewer overflows (CSOs) annually from the Mill Creek, an Ohio River tributary. When complete, LMCPR will improve water quality and serve as a catalyst to improve local neighborhoods.
-
Avoiding The Pitfalls Of PQR
Explore the fundamentals of Product Quality Reviews (PQRs), common challenges manufacturers face, strategies for streamlining PQRs, and solutions that aim to unlock the potential of a "real-time PQR."
-
Enabling Micron Level Mounting Accuracy
Explore different lens assembly techniques and how Exact Placement assembly technology addresses the requirements for the tightest possible tolerances.
-
Raise The Bar: Setting New Standards For The eCOA Industry
A paradigm shift may be necessary to increase the adoption of Electronic Clinical Outcome Assessments (eCOA) in clinical research. Explore six pivotal areas where eCOA standards can be improved.
-
Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia
Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.
-
Innovative ASD Technology Improves Abandoned Cancer Medication
Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
NEWS
-
Safeguarding Citrus: International Collaboration Between Australia And Indonesia, Targets Huánglóngbìng Threat6/25/2025
NSW Department of Primary Industries and Regional Development (NSW DPIRD) has reaffirmed its commitment to protecting Australia’s citrus industry through international collaboration against huánglóngbìng (HLB), also known as citrus greening disease.
-
Interior Cuts Red Tape To Speed Water Infrastructure In The West11/25/2025
The Department of the Interior today announced Secretary's Order 3446, which streamlines federally funded construction projects at Bureau of Reclamation facilities across the 17 Western states.
-
Higgins, Timmons Introduce Legislation To Repeal EPA Rule On Chemical Manufacturing3/11/2025
Congressman Clay Higgins (R-LA) and Congressman William Timmons (R-SC) introduced legislation to repeal the U.S. Environmental Protection Agency’s (EPA) final procedural rule for new chemical reviews under the Toxic Substances Control Act (TSCA).
-
H2APEX And Copenhagen Infrastructure Partners Enter Into Strategic Partnership For Pioneering Hydrogen Project In Lubmin8/5/2025
H2APEX Group SCA announces that Copenhagen Infrastructure Partners (CIP) – one of the world’s leading investment companies in energy infrastructure investments – has acquired a majority stake of 70% in the first phase of H2APEX’s IPCEI-funded hydrogen project in Lubmin through its Energy Transition Fund (CI ETF I) as a strategic investor.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research2/6/2025
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.